Dr. Mamta Parikh
Claim this profileUniversity of California Davis Comprehensive Cancer Center
Studies Bladder Cancer
Studies Prostate Cancer
21 reported clinical trials
36 drugs studied
Area of expertise
1Bladder Cancer
Stage IV
Stage II
Stage I
2Prostate Cancer
Stage IV
White blood cell count (WBC)
ALT
Affiliated Hospitals
Clinical Trials Mamta Parikh is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Radioactive Drug Therapy
for Prostate Cancer
This trial studies how well lutetium Lu 177 dotatate works in treating patients with a specific type of prostate cancer that has spread. The drug targets cancer cells and releases radiation to kill them. Lutetium-177 (Lu-177) PSMA therapy is a targeted treatment for advanced prostate cancer that has shown promising results.
Recruiting1 award Phase 216 criteria
More about Mamta Parikh
Clinical Trial Related5 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Mamta Parikh has experience with
- Pembrolizumab
- Cisplatin
- Gemcitabine Hydrochloride
- Niclosamide
- Prednisone
- Radium-223 Dichloride
Breakdown of trials Mamta Parikh has run
Bladder Cancer
Prostate Cancer
Kidney Cancer
Transitional Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mamta Parikh specialize in?
Mamta Parikh focuses on Bladder Cancer and Prostate Cancer. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage II.
Is Mamta Parikh currently recruiting for clinical trials?
Yes, Mamta Parikh is currently recruiting for 11 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Mamta Parikh has studied deeply?
Yes, Mamta Parikh has studied treatments such as Pembrolizumab, Cisplatin, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Mamta Parikh?
Apply for one of the trials that Mamta Parikh is conducting.
What is the office address of Mamta Parikh?
The office of Mamta Parikh is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.